Annamaria Petrungaro

Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8.

Journal: Frontiers in immunology

Published: March 12, 2026

Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 14, 2017

Venetoclax for the treatment of chronic lymphocytic leukemia.

Journal: Expert opinion on investigational drugs

Published: October 04, 2017

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Journal: Chemotherapy

Published: February 13, 2017

Pomalidomide in multiple myeloma.

Journal: Expert opinion on pharmacotherapy

Published: December 23, 2016

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

Journal: American journal of hematology

Published: November 24, 2016

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.

Journal: Leukemia research

Published: November 13, 2016

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.

Journal: American journal of hematology

Published: May 18, 2016

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

Journal: Cancer investigation

Published: February 14, 2013

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Journal: International journal of oncology

Published: June 19, 2012

Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.

Journal: Cellular immunology

Published: April 17, 2012

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB11501 and HLA-DQB10602.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 14, 2011

Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8.

Human neutrophils recognize group B streptococci via formylated peptide receptors and toll-like receptor 8.

Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies.

Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies.

Venetoclax for the treatment of chronic lymphocytic leukemia.

Venetoclax for the treatment of chronic lymphocytic leukemia.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant.

Pomalidomide in multiple myeloma.

Pomalidomide in multiple myeloma.

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.

Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB11501 and HLA-DQB10602.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB11501 and HLA-DQB10602.